栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/27 | 1,805 | 1,815 | 1,732 | 1,744 | -49 | -2.7% | 158,000 |
| 2022/01/26 | 1,770 | 1,807 | 1,770 | 1,793 | +24 | +1.4% | 68,200 |
| 2022/01/25 | 1,823 | 1,823 | 1,760 | 1,769 | -53 | -2.9% | 102,400 |
| 2022/01/24 | 1,773 | 1,824 | 1,771 | 1,822 | +22 | +1.2% | 102,900 |
| 2022/01/21 | 1,781 | 1,800 | 1,772 | 1,800 | -3 | -0.2% | 88,900 |
| 2022/01/20 | 1,798 | 1,822 | 1,787 | 1,803 | +22 | +1.2% | 70,300 |
| 2022/01/19 | 1,806 | 1,824 | 1,773 | 1,781 | -54 | -2.9% | 139,000 |
| 2022/01/18 | 1,852 | 1,861 | 1,826 | 1,835 | -14 | -0.8% | 78,900 |
| 2022/01/17 | 1,874 | 1,875 | 1,843 | 1,849 | -25 | -1.3% | 94,800 |
| 2022/01/14 | 1,900 | 1,900 | 1,856 | 1,874 | +10 | +0.5% | 192,400 |
| 2022/01/13 | 1,912 | 1,912 | 1,864 | 1,864 | -48 | -2.5% | 102,000 |
| 2022/01/12 | 1,906 | 1,914 | 1,893 | 1,912 | +34 | +1.8% | 75,900 |
| 2022/01/11 | 1,874 | 1,878 | 1,855 | 1,878 | +22 | +1.2% | 66,500 |
| 2022/01/07 | 1,867 | 1,880 | 1,843 | 1,856 | ±0 | ±0% | 127,000 |
| 2022/01/06 | 1,887 | 1,895 | 1,856 | 1,856 | -45 | -2.4% | 121,000 |
| 2022/01/05 | 1,947 | 1,947 | 1,900 | 1,901 | -41 | -2.1% | 107,400 |
| 2022/01/04 | 1,941 | 1,945 | 1,917 | 1,942 | +12 | +0.6% | 120,100 |
| 2021/12/30 | 1,927 | 1,936 | 1,916 | 1,930 | ±0 | ±0% | 28,400 |
| 2021/12/29 | 1,906 | 1,930 | 1,901 | 1,930 | +27 | +1.4% | 92,500 |
| 2021/12/28 | 1,906 | 1,906 | 1,880 | 1,903 | +20 | +1.1% | 102,800 |
| 2021/12/27 | 1,897 | 1,905 | 1,883 | 1,883 | -24 | -1.3% | 90,500 |
| 2021/12/24 | 1,911 | 1,913 | 1,897 | 1,907 | -14 | -0.7% | 96,800 |
| 2021/12/23 | 1,924 | 1,931 | 1,906 | 1,921 | +5 | +0.3% | 67,600 |
| 2021/12/22 | 1,919 | 1,919 | 1,890 | 1,916 | +6 | +0.3% | 74,000 |
| 2021/12/21 | 1,928 | 1,930 | 1,908 | 1,910 | +5 | +0.3% | 83,600 |
| 2021/12/20 | 1,905 | 1,919 | 1,893 | 1,905 | -11 | -0.6% | 131,300 |
| 2021/12/17 | 1,920 | 1,924 | 1,905 | 1,916 | -12 | -0.6% | 129,300 |
| 2021/12/16 | 1,934 | 1,940 | 1,912 | 1,928 | +3 | +0.2% | 115,800 |
| 2021/12/15 | 1,911 | 1,931 | 1,910 | 1,925 | +15 | +0.8% | 59,300 |
| 2021/12/14 | 1,947 | 1,954 | 1,899 | 1,910 | -36 | -1.8% | 118,100 |
| 2021/12/13 | 1,966 | 1,974 | 1,941 | 1,946 | -10 | -0.5% | 61,400 |
| 2021/12/10 | 1,960 | 1,980 | 1,950 | 1,956 | +12 | +0.6% | 112,700 |
| 2021/12/09 | 1,959 | 1,964 | 1,931 | 1,944 | -24 | -1.2% | 136,900 |
| 2021/12/08 | 1,969 | 1,981 | 1,960 | 1,968 | -1 | -0.1% | 98,300 |
| 2021/12/07 | 1,927 | 1,970 | 1,916 | 1,969 | +63 | +3.3% | 129,900 |
| 2021/12/06 | 1,917 | 1,934 | 1,903 | 1,906 | -25 | -1.3% | 119,300 |
| 2021/12/03 | 1,919 | 1,937 | 1,905 | 1,931 | +22 | +1.2% | 162,800 |
| 2021/12/02 | 1,897 | 1,925 | 1,897 | 1,909 | +9 | +0.5% | 240,700 |
| 2021/12/01 | 1,894 | 1,911 | 1,872 | 1,900 | +7 | +0.4% | 160,000 |
| 2021/11/30 | 1,926 | 1,939 | 1,882 | 1,893 | -18 | -0.9% | 239,200 |
| 2021/11/29 | 1,911 | 1,953 | 1,902 | 1,911 | +32 | +1.7% | 305,100 |
| 2021/11/26 | 1,888 | 1,893 | 1,871 | 1,879 | -8 | -0.4% | 113,600 |
| 2021/11/25 | 1,893 | 1,900 | 1,876 | 1,887 | +3 | +0.2% | 79,100 |
| 2021/11/24 | 1,884 | 1,901 | 1,882 | 1,884 | -4 | -0.2% | 116,000 |
| 2021/11/22 | 1,885 | 1,896 | 1,872 | 1,888 | ±0 | ±0% | 87,100 |
| 2021/11/19 | 1,890 | 1,892 | 1,875 | 1,888 | +7 | +0.4% | 90,600 |
| 2021/11/18 | 1,909 | 1,909 | 1,874 | 1,881 | -25 | -1.3% | 122,700 |
| 2021/11/17 | 1,911 | 1,914 | 1,893 | 1,906 | -13 | -0.7% | 85,900 |
| 2021/11/16 | 1,927 | 1,933 | 1,919 | 1,919 | -5 | -0.3% | 96,800 |
| 2021/11/15 | 1,937 | 1,945 | 1,923 | 1,924 | +4 | +0.2% | 95,900 |
801～
850
件表示中 / 6948件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 220,600円 | +0.4% | -8.4% | 2.40% | 28.32倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 持田薬 | 305,000円 | +3.0% | +27.5% | 2.62% | 19.31倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 146,400円 | +8.8% | +99.9% | 3.55% | 9.35倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 87,800円 | +20.3% | - | 0.00% | 154.85倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| あすかＨＤ | 231,700円 | +0.3% | +2.7% | 2.16% | 13.14倍 | 1.02倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
